A Meta-Analysis of Adherence to Antiretroviral Therapy and Virologic Responses in HIV-Infected Children, Adolescents, and Young Adults

被引:0
作者
Shoshana Y. Kahana
Jennifer Rohan
Susannah Allison
Thomas W. Frazier
Dennis Drotar
机构
[1] National Institute on Drug Abuse,Services Research Branch, Division of Epidemiology, Services and Prevention Research
[2] Cincinnati Children’s Hospital Medical Center,Infants, Children, and Adolescents Program
[3] National Institute of Mental Health,Cleveland Clinic
[4] Center for Autism and ADHD Center,Division of Behavioral Medicine and Clinical Psychology
[5] Cincinnati Children’s Hospital Medical Center,undefined
来源
AIDS and Behavior | 2013年 / 17卷
关键词
Adherence; Pediatric; Youth; Young adult; Antiretroviral therapy; Highly active; HIV;
D O I
暂无
中图分类号
学科分类号
摘要
The relationship between adherence to antiretroviral therapy (ART) and virologic outcomes in HIV+ children, adolescents, and young adults has been notably understudied, with much of the extant research focused on specific sub-literatures, such as resource-limited regions, specific clinical outcomes and time frames. The authors sought to better characterize the relationship between adherence to ART and virologic functioning along various sample and methodological factors. The authors conducted a meta-analysis of thirty-seven studies and utilized a random effects model to generate weighted mean effect sizes. In addition, the authors conducted meta-ANOVAs to examine potential factors influencing the relationship between adherence and three categories of clinical outcomes, specifically Viral Load (VL) <100, VL < 400, and continuously measured VL. The analyses included 5,344 HIV+ children, adolescents, and young adults. The relationship between adherence behaviors and virologic outcomes varied across different methods of measurement and analysis. The relationship between adherence and continuously measured VL was significantly larger than for dichotomously-coded VL < 400 at Qb (20.69(1), p < .0005). Caregiver self-report indices elicited very small to small magnitude effects across both VL < 100 and VL < 400 outcomes and combined informant reporting (youth/adolescent and parent) produced significantly larger effects than caregiver report alone with adherence and VL < 400 outcomes at Qb (9.28(1), p < .005). More recently published trials reported smaller relationships between adherence and categorical clinical outcomes, such that year of publication significantly negatively correlated with VL < 100 (r = −.71(14), p < .005) and VL < 400 (r = −.43(26), p < .02). The data suggest that the magnitude of the relationship between ART adherence and virologic outcomes among heterogeneous samples of HIV+ children, adolescents and young adults varies across virologic outcomes and may be affected by moderating sample and methodological factors. Methodological and research recommendations for the interpretation of the current findings as well as for future HIV adherence related research are presented.
引用
收藏
页码:41 / 60
页数:19
相关论文
共 231 条
[21]  
Sutcliffe CG(2005)Assessment of adherence to highly active antiretroviral therapy in a cohort of African HIV-infected children in Abidjan, Cote d’Ivoire J Acquir Immune Defic Syndr 40 498-3
[22]  
van Dijk JH(2004)Virologic and immunologic outcomes after 24 weeks in HIV type 1-infected adolescents receiving highly active antiretroviral therapy J Infect Dis 190 271-1402
[23]  
Bolton C(2009)Multimethod adherence assessment in children with perinatally acquired HIV-1: The influence of off-schedule dosing in predicting biological markers Pediatr Infect Dis J 29 1-62
[24]  
Persaud D(2003)Adherence to antiretroviral therapy and its determinants in children with human immunodeficiency virus infection: a multicentre, national study Acta Paediatr 92 1398-569
[25]  
Moss WJ(2003)Adherence to prescribed antiretroviral therapy in human immunodeficiency virus-infected children in the PENTA 5 trial Pediatr Infect Dis J 22 56-e597
[26]  
Ciaranello AL(2008)High prevalence of antiretroviral drug resistance mutations in HIV-1 non-B subtype strains from African children receiving antiretroviral therapy regimen according to the 2006 revised WHO recommendations J Acquir Immune Defic Syndr 49 566-191
[27]  
Chang Y(2011)Excellent adherence to antiretrovirals in HIV+ Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effects PLoS One 6 e18505-1176
[28]  
Margulis AV(2004)Integrating adherence to highly active antiretroviral therapy into children’s daily lives: a qualitative study Pediatrics 114 e591-973
[29]  
Sabin CA(2006)A comprehensive programme to strengthen adherence to antiretroviral drug therapy and achieve virological control in HIV infected children in Thailand Vulnerable Child Youth Stud 1 180-537
[30]  
Smith CJ(2001)Assessment of adherence with medications in human immunodeficiency virus-infected children Pediatr Infect Dis J 20 1174-601